| P50 | author | Bin Liu | Q43176205 |
| | Youyong Yuan | Q61160419 |
| P2093 | author name string | Bin Liu | |
| | Youyong Yuan | |
| P2860 | cites work | Redox activation of metal-based prodrugs as a strategy for drug delivery | Q27025736 |
| | Rational design of fluorescent light-up probes based on an AIE luminogen for targeted intracellular thiol imaging. | Q39061939 |
| | Meta-analysis of cellular toxicity for cadmium-containing quantum dots | Q39960471 |
| | Tuning the singlet-triplet energy gap: a unique approach to efficient photosensitizers with aggregation-induced emission (AIE) characteristics | Q41084525 |
| | Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics | Q42834435 |
| | ZnO-functionalized upconverting nanotheranostic agent: multi-modality imaging-guided chemotherapy with on-demand drug release triggered by pH. | Q44546851 |
| | Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation | Q46563550 |
| | A Photoactivatable AIE Polymer for Light-Controlled Gene Delivery: Concurrent Endo/Lysosomal Escape and DNA Unpacking. | Q46712165 |
| | Far-Red and Near-IR AIE-Active Fluorescent Organic Nanoprobes with Enhanced Tumor-Targeting Efficacy: Shape-Specific Effects. | Q48670779 |
| | Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells | Q48683964 |
| | Far-red fluorescence probe for monitoring singlet oxygen during photodynamic therapy | Q50463998 |
| | Targeted bioimaging and photodynamic therapy of cancer cells with an activatable red fluorescent bioprobe. | Q50466607 |
| | Multifunctional organic nanoparticles with aggregation-induced emission (AIE) characteristics for targeted photodynamic therapy and RNA interference therapy. | Q51564636 |
| | Synthesis and Design of Aggregation-Induced Emission Surfactants: Direct Observation of Micelle Transitions and Microemulsion Droplets. | Q51683513 |
| | Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. | Q53637592 |
| | A self-reporting AIE probe with a built-in singlet oxygen sensor for targeted photodynamic ablation of cancer cells. | Q55166786 |
| | Mitochondria-targeted aggregation induced emission theranostics: crucial importance of activation | Q58374433 |
| | A FRET probe with AIEgen as the energy quencher: dual signal turn-on for self-validated caspase detection. | Q64989808 |
| | Cell Death in Development | Q67531415 |
| | Drug delivery and targeting | Q74525964 |
| | Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission | Q86538230 |
| | Real-time monitoring of cell apoptosis and drug screening using fluorescent light-up probe with aggregation-induced emission characteristics | Q87416494 |
| | Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy | Q91189185 |
| | Mitochondria and cancer | Q29616610 |
| | Stimuli-Responsive Materials for Controlled Release of Theranostic Agents. | Q30406730 |
| | Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging | Q30813719 |
| | NIR dyes for bioimaging applications | Q33643097 |
| | Light-up probe based on AIEgens: dual signal turn-on for caspase cascade activation monitoring | Q33662089 |
| | Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristics | Q33882184 |
| | Aggregation-induced emission of siloles | Q33886473 |
| | Singlet oxygen: there is indeed something new under the sun. | Q34122315 |
| | Aggregation-Induced Emission: Together We Shine, United We Soar! | Q34499058 |
| | Imaging and cancer: a review | Q34977050 |
| | The rise and rise of drug delivery | Q36111904 |
| | Prodrugs: design and clinical applications. | Q37064858 |
| | Emissive nanoparticles from pyridinium-substituted tetraphenylethylene salts: imaging and selective cytotoxicity towards cancer cells in vitro and in vivo by varying counter anions | Q37707849 |
| | Caspases and cancer | Q37860139 |
| | Bio-inspired, bioengineered and biomimetic drug delivery carriers | Q37896455 |
| | Bioprobes based on AIE fluorogens | Q38112482 |
| | Smart chemistry in polymeric nanomedicine. | Q38221776 |
| | Functional nanomaterials for phototherapies of cancer. | Q38254668 |
| | Biosensing by luminogens with aggregation-induced emission characteristics | Q38265449 |
| | Specific light-up bioprobes based on AIEgen conjugates | Q38357398 |
| | Small conjugate-based theranostic agents: an encouraging approach for cancer therapy. | Q38539464 |
| | Highly Efficient Far Red/Near-Infrared Solid Fluorophores: Aggregation-Induced Emission, Intramolecular Charge Transfer, Twisted Molecular Conformation, and Bioimaging Applications. | Q38818915 |
| | Smart Probe for Tracing Cancer Therapy: Selective Cancer Cell Detection, Image-Guided Ablation, and Prediction of Therapeutic Response In Situ | Q38859857 |
| | A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells. | Q38883923 |
| | Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells. | Q38928691 |
| | Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment | Q38939943 |
| | A pH-activatable and aniline-substituted photosensitizer for near-infrared cancer theranostics. | Q38958629 |
| | Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking | Q38964655 |
| | A multifunctional nanomicelle for real-time targeted imaging and precise near-infrared cancer therapy | Q38973416 |
| | Targeted and image-guided photodynamic cancer therapy based on organic nanoparticles with aggregation-induced emission characteristics | Q38981048 |
| | Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source. | Q38991558 |
| | Imaging intracellular anticancer drug delivery by self-assembly micelles with aggregation-induced emission (AIE micelles). | Q39017562 |
| | A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation | Q39019063 |
| | Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. | Q39047691 |
| P433 | issue | 4 | |
| P921 | main subject | visualization | Q451553 |
| | drug delivery | Q1392806 |
| P304 | page(s) | 2537-2546 | |
| P577 | publication date | 2017-01-18 | |
| P1433 | published in | Chemical Science | Q2962267 |
| P1476 | title | Visualization of drug delivery processes using AIEgens | |
| P478 | volume | 8 | |